Contact

Please select a country

us@pharmalex.com

Contact United States

TwitterLinkedin
contact@pharmalex.com
Search
PharmaLexPharmaLex
PharmaLex
Confidence Beyond Compliance
  • About Us
    • About Us
    • Management Team
    • Industry Expertise
      • Biopharma
      • Customer On-site Support
      • Medical Device Services
      • Portfolio Maintenance Outsourcing
    • What Our Clients Say About Us
    • Our Approach
    • Resource Library
  • Our Services
    • Choose a Service
    • InnoPHLEX
    • SourcePHLEX
    • Development Consulting
    • Regulatory Affairs
    • Quality Management & Compliance
    • Pharmacovigilance, Epidemiology & Risk Management
    • Medical Device Services
    • Brexit
  • News & Events
    • News
    • Webinars
    • Events
  • Countries
  • Contact us
  • Careers
    • Current Opportunities
    • Why work at PharmaLex
    • Working at PharmaLex
Menu back  
Home > News & Events > Webinar > Data Science: Strategy For A Successful Quality By Design Implementation

Data Science: Strategy For A Successful Quality By Design Implementation

Tuesday, March 20th 

15:00 PM – CEST / 09:00 AM EDT

Register here >>

Providing quality to patients, reducing production costs and facilitating new drug process approvals

In this complimentary webinar, our experts discuss Quality by Design,  Design of Experiment, Bayesian statistics, Risk, Control Strategy and Comparison. We explain analytical methods developed to support and control various processes and discuss examples from case studies.

At end of the webinar, Dr. Bruno Boulanger will answer your questions in a Q&A session.

Key learnings:

  • Quality by Design strategy to successfully implement a model-based process development and evaluate its relation to risk
  • Understanding Data Science concepts such as Design Space and Value of Modeling
  • Connecting the dots between processes, analytical procedures and clinical trial results for a comprehensive development, qualification and process control

You may address your questions at: contact@pharmalex.com

Featured Speaker:

Dr. Bruno Boulanger, CSO, Company Co-Founder of Arlenda, PharmaLex Statistical Division

Dr. Bruno Boulanger holds a PhD in Experimental Psychology from the University of Liège (Belgium). After a post-doctorate at the Université Catholique de Louvain (Belgium) and the University of Minnesota (USA) in Statistics applied to simulation of clinical trials, he joined Eli Lilly in Belgium in 1990. He has gathered 20 years of experience in several areas of pharmaceutical research and industry including discovery, toxicology, CMC and early clinical phases. He held various positions in Europe and in the US. Since 2000, Dr. Boulanger is Senior Lecturer at the Université of Liège, in the School of Pharmacy, teaching Design of Experiments and statistics. He organizes and contributes to Non-Clinical Statistics in Europe. In 2010, he set up the First Applied Bayesian Statistics conference. He is also a USP Expert, member of the Committee of Experts in Statistics. Dr. Boulanger has authored or co-authored more than 100 publications in applied statistics.

Contact

Related posts
Environmental Risk Assessments for Human Medicinal Products – Challenges and Recent Developments
31st July 2018
EudraVigilance – The fundamental tool for Pharmacovigilance
20th July 2018
ISO IDMP Implementation in Europe – how SPOR will change the Regulatory Environment
1st June 2018
Brexit: An update on preparations for MA holders
12th April 2018
ATMP: Understanding the Regulatory Landscape
21st February 2018
Mergers & Acquisitions (M&A) related activities – A Regulatory Affairs perspective
25th November 2017
Search
Recent News
  • Top 10 Tips for an effective Internal Audit System
    20th February 2019
  • Use and Learn Period for Serialisation
    14th February 2019
  • Cleaning Validation
    13th February 2019
  • Brexit: Update for the Pharma Industry
    7th February 2019
  • How can you add value to your Self-Inspection Programme?
    30th January 2019
  • Webinar // Early Phase Modelling – Estimating the Costs and Effectiveness of a Pharmaceutical before Clinical Trial
    25th January 2019
Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
  • Will you be at DIA RSIDM 2019 in North Bethesda? If you are, make sure you stop by our booth and say hello.… https://t.co/tMVDOLWmw524 days ago
  • Take part in our survey on pharmaceutical serialization. It only takes a few minutes and helps us identify some of… https://t.co/bw1DQP5N3224 days ago
NEWSLETTER SIGN UP










View our privacy policy

WHAT OUR CLIENTS SAY
  • PharmaLex is dedicated to delivering a comprehensive portfolio while their modular approach allows tailor-made solutions. They acknowledge our feedback, modify their approach and adapt accordingly.

    Top 10 Pharma Company
    President
PharmaLex
©2018 PharmaLex GmbH. All rights reserved.

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. These emails are being sent from @pharmalexcompanies.com and are not from us. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.

Privacy Policy

This can be specific information about signing up to the newsletter.

Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.